Wealthspire Advisors (Maryland)’s Avanos Medical AVNS Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-200	Closed	-$9K	–	586
2019 Q1	$9K	Buy	200 +14	+8%	+$627	﹤0.01%	1565
2018 Q4	$8K	Hold	186	–	–	﹤0.01%	1534
2018 Q3	$13K	Hold	186	–	–	﹤0.01%	1430
2018 Q2	$11K	Hold	186	–	–	﹤0.01%	1487
2018 Q1	$9K	Hold	186	–	–	﹤0.01%	1600
2017 Q4	$9K	Sell	186 -175	-48%	-$8.04K	﹤0.01%	1620
2017 Q3	$16K	Buy	361 +161	+81%	+$6.87K	﹤0.01%	1373
2017 Q2	$8K	Hold	200	–	–	﹤0.01%	1602
2017 Q1	$8K	Hold	200	–	–	﹤0.01%	1396
2016 Q4	$7K	Hold	200	–	–	﹤0.01%	1315
2016 Q3	$7K	Hold	200	–	–	﹤0.01%	1314
2016 Q2	$7K	Buy	200 +20	+11%	+$613	﹤0.01%	1259
2016 Q1	$5K	Sell	180 -379	-68%	-$10.1K	﹤0.01%	1328
2015 Q4	$19K	Buy	+559	New	+$17.4K	﹤0.01%	980

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s AVNS Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of Avanos Medical (AVNS) in Q2 2019, closing a stake of 200 shares — an estimated $9K sold.

Wealthspire Advisors (Maryland) first reported a position in AVNS in Q4 2015 and held it in 14 quarters. The position peaked at $19K in Q4 2015. 317 funds tracked by Wall St. Rank hold AVNS as of Q2 2019.

Wealthspire Advisors (Maryland) reported no remaining Avanos Medical position as of Q2 2019 after selling out during the quarter.
Wealthspire Advisors (Maryland) sold 200 Avanos Medical shares in Q2 2019, an estimated $9K.
Wealthspire Advisors (Maryland) first reported a position in Avanos Medical in Q4 2015 and held it in 14 quarters.
Wealthspire Advisors (Maryland)'s Avanos Medical position peaked at $19K in Q4 2015.
317 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.